Notes and references
1 J. A. Prescher and C. R. Bertozzi, Nat. Chem. Biol., 2005, 1, 13.
2 M. D. Best, Biochemistry, 2009, 48, 6571.
3 E. M. Sletten and C. R. Bertozzi, Angew. Chem., Int. Ed., 2009,
48, 6974.
4 Y.-X. Chen, G. Triola and H. Waldmann, Acc. Chem. Res., 2011,
DOI: 10.1021/ar200046h.
5 M. F. Debets, C. W. J. van der Doelen, F. P. J. T. Rutjes and
F. L. van Delft, ChemBioChem, 2010, 11, 1168.
6 V. V. Rostovtsev, L. G. Green, V. V. Fokin and K. B. Sharpless,
Angew. Chem., Int. Ed., 2002, 41, 2596.
7 C. W. Tornøe, C. Christensen and M. Meldal, J. Org. Chem., 2002,
67, 3057.
8 P. V. Chang, X. Chen, C. Smyrniotis, A. Xenakis, T. Hu,
C. R. Bertozzi and P. Wu, Angew. Chem., Int. Ed., 2009, 48, 4030.
9 V. Hong, N. F. Steinmetz, M. Manchester and M. G. Finn,
Bioconjugate Chem., 2010, 21, 1912.
10 D. Soriano Del Amo, W. Wang, H. Jiang, C. Besanceney,
A. C. Yan, M. Levy, Y. Liu, F. L. Marlow and P. Wu, J. Am.
Chem. Soc., 2010, 132, 16893.
11 D. C. Kennedy, R. K. Lyn and J. P. Pezacki, J. Am. Chem. Soc.,
2009, 131, 2444.
12 J. P. Pezacki, J. A. Blake, D. C. Danielson, D. C. Kennedy,
R. K. Lyn and R. Singaravelu, Nat. Chem. Biol., 2011, 7, 137.
13 P. V. Chang, J. A. Prescher, M. J. Hangauer and C. R. Bertozzi,
J. Am. Chem. Soc., 2007, 129, 8400.
14 N. J. Agard, J. A. Prescher and C. R. Bertozzi, J. Am. Chem. Soc.,
2004, 126, 15046.
15 J. M. Baskin, J. A. Prescher, S. T. Laughlin, N. J. Agard,
P. V. Chang, I. A. Miller, A. Lo, J. A. Codelli and
C. R. Bertozzi, Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 16793.
16 P. V. Chang, J. A. Prescher, E. M. Sletten, J. M. Baskin,
I. A. Miller, N. J. Agard, A. Lo and C. R. Bertozzi, Proc. Natl.
Acad. Sci. U. S. A., 2010, 107, 1821.
Fig. 1 In situ labeling of EGF–EGFR interactions via SPANC in
MDA-MB-468 cells. (a) Cyclic nitrone modified EGF-1c bound to
EGFR was labeled by SPANC with 2b-biotin for 30 min prior to
streptavidin-FITC fluorescent labeling. (b) Fluorescence (top) and
bright field (bottom) image of in situ SPANC as described in (a). (c)
Negative control, cells pretreated with EGF followed by treatment
with 2b-biotin and streptavidin-FITC, fluorescence (top) and bright
field (bottom) image. Reagent concentrations: EGF-1c (10 mM), EGF
(10 mM), 2b-biotin (10 mM) and streptavidin-FITC (5 mg mLꢁ1).
17 X. Ning, J. Guo, M. A. Wolfert and G.-J. Boons, Angew. Chem.,
Int. Ed., 2008, 47, 2253.
18 A. A. Poloukhtine, N. E. Mbua, M. A. Wolfert, G.-J. Boons and
V. V. Popik, J. Am. Chem. Soc., 2009, 131, 15769.
19 M. F. Debets, S. S. van Berkel, S. Schoffelen, F. P. J. T. Rutjes,
J. C. M. van Hest and F. L. van Delft, Chem. Commun., 2010, 46, 97.
20 J. C. Jewett, E. M. Sletten and C. R. Bertozzi, J. Am. Chem. Soc.,
2010, 132, 3688.
21 J. Dommerholt, S. Schmidt, R. Temming, L. J. A. Hendriks,
F. P. J. T. Rutjes, J. C. M. van Hest, D. J. Lefeber, P. Friedl
and F. L. van Delft, Angew. Chem., Int. Ed., 2010, 49, 9422.
22 K. Gutsmiedl, C. T. Wirges, V. Ehmke and T. Carell, Org. Lett.,
2009, 11, 2405.
23 M. L. Blackman, M. Royzen and J. M. Fox, J. Am. Chem. Soc.,
2008, 130, 13518.
24 N. K. Devaraj, R. Upadhyay, J. B. Haun, S. A. Hilderbrand and
R. Weissleder, Angew. Chem., Int. Ed., 2009, 48, 7013.
25 W. Song, Y. Wang, Z. Yu, C. I. R. Vera, J. Qu and Q. Lin, ACS
Chem. Biol., 2010, 5, 875.
26 Y. A. Lin, J. M. Chalker and B. G. Davis, ChemBioChem, 2009,
10, 959.
27 J. Moran, C. S. McKay and J. P. Pezacki, Can. J. Chem., 2011,
89, 148.
28 B. C. Sanders, F. Friscourt, P. A. Ledin, N. E. Mbua, S. Arumugam,
J. Guo, T. J. Boltje, V. V. Popik and G. J. Boons, J. Am. Chem. Soc.,
2011, 133, 949.
29 C. S. McKay, J. Moran and J. P. Pezacki, Chem. Commun., 2010,
46, 931.
Cellular labeling was accomplished by in situ SPANC reactions
of cyclic nitrone modified EGF with DIBO-biotin and secondary
labeling with streptavidin-FITC (Fig. 1b). For the negative
control, MDA-MD-468 cells were pretreated with unmodified
EGF followed by treatment with DIBO-biotin and streptavidin-
FITC (Fig. 1c).
In summary, we have shown that five membered cyclic
nitrones blend fast kinetics with enhanced stability in SPANC
reactions with dibenzocyclooctynes. Reactions of cyclic nitrones
proceeded with rate constants up to 3.38 ꢀ 0.31 Mꢁ1 sꢁ1 in
CD3CN, or 59 times faster than the analogous reaction of
benzyl azide with DIBO. We have demonstrated highly specific
direct labeling of BSA and EGF in vitro and have shown
efficient labeling of EGFRs on the surface of cancer cells via
SPANC. The SPANC bioconjugation approach presented
here is modular and can be extended to other biological
imaging applications, since cyclic nitrone functionalities can
be easily conjugated to carboxylic acid or amine containing
biomolecules.
30 X. Ning, R. P. Temming, J. Dommerholt, J. Guo, D. B. Ania,
M. F. Debets, M. A. Wolfert, G.-J. Boons and F. L. van Delft,
Angew. Chem., Int. Ed., 2010, 49, 3065.
31 J. Marco-Contelles, Angew. Chem., Int. Ed., 2004, 43, 2198.
32 C. S. McKay, D. C. Kennedy and J. P. Pezacki, Tetrahedron Lett.,
2009, 50, 1893.
c
10042 Chem. Commun., 2011, 47, 10040–10042
This journal is The Royal Society of Chemistry 2011